Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK.
Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.
FEMS Microbiol Rev. 2019 Sep 1;43(5):548-575. doi: 10.1093/femsre/fuz016.
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis, remains one of the leading causes of mortality across the world. There is an urgent requirement to build a robust arsenal of effective antimicrobials, targeting novel molecular mechanisms to overcome the challenges posed by the increase of antibiotic resistance in TB. Mycobacterium tuberculosis has a unique cell envelope structure and composition, containing a peptidoglycan layer that is essential for maintaining cellular integrity and for virulence. The enzymes involved in the biosynthesis, degradation, remodelling and recycling of peptidoglycan have resurfaced as attractive targets for anti-infective drug discovery. Here, we review the importance of peptidoglycan, including the structure, function and regulation of key enzymes involved in its metabolism. We also discuss known inhibitors of ATP-dependent Mur ligases, and discuss the potential for the development of pan-enzyme inhibitors targeting multiple Mur ligases.
结核病(TB)是由细胞内病原体结核分枝杆菌引起的,仍然是全球主要的死亡原因之一。迫切需要建立一个强大的有效抗菌药物库,针对新的分子机制,以克服结核分枝杆菌抗生素耐药性增加带来的挑战。结核分枝杆菌具有独特的细胞包膜结构和组成,含有肽聚糖层,对维持细胞完整性和毒力至关重要。参与肽聚糖生物合成、降解、重塑和循环利用的酶已重新成为抗感染药物发现的有吸引力的靶点。在这里,我们综述了肽聚糖的重要性,包括其结构、功能和代谢中关键酶的调节。我们还讨论了已知的 ATP 依赖性 Mur 连接酶抑制剂,并讨论了开发针对多种 Mur 连接酶的泛酶抑制剂的潜力。